Kirk M Maxey

This inventor holds 14 USPTO granted patents and 3 published patent applications and 4 EPO patents. Top assignees: Cayman Chemical Company Incorporated, Corgenix Medical Corporation. Active years: 2008-2024.

USPTO Granted Patents = 14 (Patent Applications = 3)

% Patents Active = 85.7

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 15(Granted Patents)

Location History:

Fort Collins, CO (US) (2008 - 2010)
Ann Arbor, MI (US) (2010 - 2024)

Company Filing History:

13 out of 29

Cayman Chemical Company Incorporated

patents

3 out of 3

Corgenix Medical Corporation

patents

where one patent can have more than one assignee

Years Active: 2008-2024

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11884624 - Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions (2024-01-30),

2. 11066361 - Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions (2021-07-20),

3. 10556862 - Difluorolactam compounds as EPreceptor-selective agonists for use in the treatment of EP-mediated diseases and conditions (2020-02-11),

4. 9688627 - [object Object] (2017-06-27),

5. 9676712 - [object Object] (2017-06-13),

6. 9487478 - Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions (2016-11-08),

7. 9180116 - Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions (2015-11-10),

8. 8168400 - Methods and kits for detection of thromboxane A2 metabolites (2012-05-01),

9. 8105790 - Methods and kits for detection of thromboxane A2 metabolites (2012-01-31),

10. 8063240 - Prostaglandin E1 and E2 analogs for the treatment of various medical conditions (2011-11-22),

11. 7727730 - Methods and kits for detection of thromboxane A2 metabolites (2010-06-01),

12. 7674921 - [object Object] (2010-03-09),

13. 7585889 - [object Object] (2009-09-08),

14. 7358275 - Internal 1,15-lactones of fluprostenol and related prostaglandin F2a analogs and their use in the treatment of glaucoma and intraocular hypertension (2008-04-15),

Title: The Innovative Journey of Kirk M. Maxey

Introduction:

Kirk M. Maxey, a talented inventor hailing from Ann Arbor, MI, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents:

Kirk M. Maxey holds several patents in various fields, including telecommunications, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights:

Throughout his illustrious career, Kirk M. Maxey has been recognized for his innovative spirit and problem-solving abilities. His inventions have revolutionized industries and improved the lives of many around the globe.

Collaborations:

Kirk M. Maxey has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His partnerships have been instrumental in the successful development and commercialization of his groundbreaking ideas.

Conclusion:

In conclusion, Kirk M. Maxey stands as a beacon of innovation, with a remarkable track record of turning visionary ideas into tangible solutions that have a lasting impact on society. His dedication to pushing the boundaries of what is possible continues to inspire inventors and innovators worldwide.